Keyphrases
Patient Management
100%
Kawasaki Disease
100%
Intravenous Immunoglobulin (IVIg)
100%
Pharmacologic Management
100%
Practice Variation
100%
Coronary Artery Aneurysm
100%
Acetylsalicylic Acid
75%
Disease Registry
75%
Beta-blockers
50%
Statins
50%
Primary Therapy
50%
Randomized Controlled Trial
25%
Second Dose
25%
Efficient Strategy
25%
Anticoagulation
25%
Adjunctive Therapy
25%
Anti-inflammatory Agents
25%
One-center
25%
Therapy Strategy
25%
Abciximab
25%
Infliximab
25%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
25%
Antiplatelet
25%
Knowledge Gaps
25%
Clopidogrel
25%
Antiplatelet Therapy
25%
Intravenous Immunoglobulin Therapy
25%
Anticoagulation Strategy
25%
Persistent Fever
25%
Intravenous Steroids
25%
Design Practice
25%
Quality Collaborative
25%
Nursing and Health Professions
Immunoglobulin
100%
Coronary Artery Aneurysm
100%
Patient with Kawasaki Disease
100%
Mucocutaneous Lymph Node Syndrome
75%
Disease Registry
75%
Alka-Seltzer
75%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Beta Adrenergic Receptor Blocking Agent
50%
Anticoagulation
50%
Adjuvant Therapy
25%
Nonsteroid Antiinflammatory Agent
25%
Immunotherapy
25%
Clopidogrel
25%
Antiinflammatory Agent
25%
Infliximab
25%
ReoPro
25%
Medicine and Dentistry
Immunoglobulin
100%
Coronary Artery Aneurysm
100%
Patient with Kawasaki Disease
100%
Acetylsalicylic Acid
75%
Kawasaki Disease
75%
Beta Adrenergic Receptor Blocking Agent
50%
Anticoagulation
50%
Antiplatelet
50%
Statin
50%
Randomized Controlled Trial
25%
Adjuvant Therapy
25%
Infliximab
25%
Nonsteroid Antiinflammatory Agent
25%
Clopidogrel
25%
Antiinflammatory Agent
25%
Abciximab
25%
Intravenous Immunoglobulin Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
100%
Mucocutaneous Lymph Node Syndrome
100%
Coronary Artery Aneurysm
100%
Acetylsalicylic Acid
75%
Beta Adrenergic Receptor Blocking Agent
50%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Antiplatelet
50%
Randomized Controlled Trial
25%
Immunotherapy
25%
Antiinflammatory Agent
25%
Abciximab
25%
Infliximab
25%
Clopidogrel
25%
Non-Steroidal Anti-Inflammatory Drug
25%